Vaccine Clinical Trial
Official title:
Maternal to Neonatal Transmission Antibody Covid-19 Study - The TRAB CoV-19
This is a prospective clinical study aiming to investigate on the transplacental antibody transmission post Covid-19 infection during pregnancy.
Covid -19 infection has been a significant public health burden as it shifted the paradigm of infectious diseases aiming to control the spread and enhance public immune protection. The introduction of Covid -19 vaccination in December 2020 aimed to combat the infection, thus tremendously helping to flatten the disease worldwide. Channeling the vaccine for the obstetrics field is one of the hallmark strategies to reduce maternal morbidity and mortality. The efficacy of vaccination for the pregnant lady has been established. However, fetus protection via transmission of the antibody during pregnancy is still uncertain. Therefore, this study aims to consolidate further evidence of transplacental antibody post-maternal vaccination aiming for fetal protection following delivery. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04460235 -
Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma
|
Phase 4 | |
| Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
| Completed |
NCT00401505 -
Rubella Susceptibility in Multiparous Women
|
||
| Recruiting |
NCT05054621 -
Immunogenicity of COVID-19 Vaccine on Heterologous Schedule
|
Phase 2 | |
| Completed |
NCT05083065 -
Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
|
||
| Recruiting |
NCT05085145 -
Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV
|
Phase 4 | |
| Completed |
NCT05046548 -
This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19
|
Phase 1/Phase 2 | |
| Completed |
NCT01961960 -
A Study to Evaluate Intramuscular ASP7374
|
Phase 3 | |
| Completed |
NCT01961947 -
Study of ASP7374, Cell-culture-derived Influenza Vaccine
|
Phase 3 | |
| Completed |
NCT00401700 -
Influenza Vaccine Postpartum Questionnaire
|
||
| Completed |
NCT03300050 -
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine
|
Phase 1 | |
| Completed |
NCT01015703 -
Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00560066 -
Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
|
Phase 4 | |
| Active, not recruiting |
NCT05099965 -
Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)
|
Phase 2 | |
| Recruiting |
NCT04638985 -
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR
|
Phase 4 | |
| Recruiting |
NCT06136832 -
Pneumonia Vaccine Education Intervention Study
|
N/A | |
| Active, not recruiting |
NCT04741828 -
Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
|
Phase 2/Phase 3 | |
| Completed |
NCT05083039 -
Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19
|
||
| Completed |
NCT03714737 -
Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese
|
Phase 3 | |
| Completed |
NCT04664309 -
Understanding Immunity to the COVID-19 Vaccines
|